Food News and Research

RSS

Also in Global Health News: Food production and climate change; Poverty and hunger in India; Composting toilets in Malawi

A new discussion paper, led by a researcher from the University of Nairobi and produced by the International Food Policy Research Institute, examines how 10 sub-Saharan African countries have adapted food production to mitigate the effects of climate change, IRIN reports. The paper found that most countries use crops that mature faster and are tolerant of frequent and intense droughts.

9 Aug 2010

FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patients

Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant factor VIII product indicated for both the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A.

9 Aug 2010

Fibrocell Science submits clinical study report to FDA for azficel-T Phase II/III trial for acne scars

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted a clinical study report for its Phase II/III study of azficel-T for the treatment of moderate to severe acne scars to the U.S. Food & Drug Administration (FDA).

9 Aug 2010

FDA accepts Salix's XIFAXAN550 sNDA for Priority Review

Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (NDA) for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.

9 Aug 2010

AMS AdVance XP sling for male stress urinary incontinence receives CE Mark

American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today the company received CE Mark for AdVance XP. The device is the latest generation of AMS' AdVance sling, a minimally invasive implant for the treatment of male stress urinary incontinence (SUI).

9 Aug 2010

CryoPatch SG pulmonary human cardiac patch receives FDA clearance for 5-year shelf-life extension

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.

9 Aug 2010

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

Clinical Data, Inc. today announced operational and financial results for the first quarter ended June 30, 2010, noting key accomplishments including the acceptance of the Company's new drug application (NDA) for vilazodone by the U.S. Food and Drug Administration (FDA) and the successful completion of a public offering .

9 Aug 2010

GTx second-quarter net loss increases to $12.9 million

GTx, Inc. today reported financial results for the second quarter of 2010. The net loss for the quarter ended June 30, 2010 was $12.9 million compared with a net loss of $11.3 million for the quarter ended June 30, 2009. The net loss for the second quarter of 2010 included a $1.7 million non-cash impairment charge related to the conclusion of the Phase III clinical trial of toremifene 20 mg.

9 Aug 2010

China-Biotics net sales for first-quarter fiscal 2011 increase 61.8% to $24.9 million

China-Biotics, Inc., a leading developer, manufacturer and distributor of probiotics products in China, today reported its financial results for the first quarter of its 2011 fiscal year, ended June 30, 2010.

9 Aug 2010

Osteotech second-quarter revenue increases 2% to $24.0 million

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the second quarter ended June 30, 2010.

9 Aug 2010

New Irish collaborative seaweed cultivation project

Stop anyone in the street and ask them which country is the most famous for eating seaweed, and nine times out of ten, the answer will be "Japan". But did you know that Ireland has at least a 900-year old tradition of eating seaweed!

9 Aug 2010

Allergy shots can cause systemic side effects: Study

Allergy shots can reduce symptoms of asthma, use of inhaled medications and allergy-related asthma attacks, confirms an updated review of studies. Yet, the treatment can also cause systemic side effects that range from a stuffy nose to fatal anaphylactic shock.About 30 percent of asthma patients experience improved breathing after receiving a series of injections that desensitize their immune systems to specific irritants, according to the review. The medical term for this treatment protocol is allergen immunotherapy.

9 Aug 2010

45-year-old Hummelstown patient takes on FDA over Johnson & Johnson’s antibiotic Levaquin

Suffering from injuries to his brain, nerves, and tendons for over four years, 45-year-old John Fratti of Hummelstown, PA, has taken on the Food and Drug Administration with good results. Since taking Johnson & Johnson’s antibiotic Levaquin for an infection he has had many diagnostic studies on his brain and body that show considerable damage. Healthy and athletic at 41 years of age, he now takes multiple prescription pain medications for his injuries.

7 Aug 2010

Ironwood provides investor update for second-quarter 2010

Ironwood Pharmaceuticals, Inc. today provided an update on its business activities for the second quarter of 2010.

7 Aug 2010

EpiCept second-quarter net loss decreases to $4.9 million

EpiCept Corporation today announced operating and financial results for the three and six months ended June 30, 2010, and provided an update with respect to the Company's key business initiatives.

7 Aug 2010

IDFA applauds U.S Senate Committee for child nutrition legislation

The International Dairy Foods Association applauded the leadership of Chairman Blanche Lincoln (D-AR), U.S. Senate Committee on Agriculture, Nutrition and Forestry, on the passage of child nutrition legislation that strengthens federal feeding programs. The federal child nutrition programs include the National School Lunch Program, School Breakfast Program, Special Supplemental Program for Women Infants, and Children (WIC) and the Child and Adult Care Food Program.

7 Aug 2010

Sucampo Pharmaceuticals second-quarter 2010 total revenue declines to $13.8 million

Sucampo Pharmaceuticals, Inc. today reported its consolidated financial results for the quarter and six months ended June 30, 2010.

7 Aug 2010

mGive, disaster relief partners launch campaigns to aid flood-affected victims in Pakistan

In response to the damaging floods that struck Pakistan this week, mGive and several of its disaster relief partners quickly mobilized to launch text donation campaigns that will aid victims by distributing tents, relief supplies and humanitarian assistance. According to the UN, at least 1,400 people have died and more than three million people have been affected by the floods, which are the worst in Pakistan's history.

7 Aug 2010

Researchers examine differences in eating habits of African Americans

Researchers looking for differences in eating habits of African Americans based on whether or not they had Type 2 diabetes uncovered an unexpected result: No matter what the blood sugar level was, the dietary intakes were pretty much the same.

7 Aug 2010

ADA commends U.S. Senate on reauthorization of child nutrition programs

The American Dietetic Association commends the U.S. Senate for its bipartisan action Thursday, August 5, to reauthorize the nation's crucial child nutrition programs. The Healthy, Hunger-Free Kids Act of 2010 covers programs reaching millions of children that were scheduled expire September 30.

7 Aug 2010

Food News and Research

Also in Global Health News: Food production and climate change; Poverty and hunger in India; Composting toilets in Malawi

FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patients

Fibrocell Science submits clinical study report to FDA for azficel-T Phase II/III trial for acne scars

FDA accepts Salix's XIFAXAN550 sNDA for Priority Review

AMS AdVance XP sling for male stress urinary incontinence receives CE Mark

CryoPatch SG pulmonary human cardiac patch receives FDA clearance for 5-year shelf-life extension

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

GTx second-quarter net loss increases to $12.9 million

China-Biotics net sales for first-quarter fiscal 2011 increase 61.8% to $24.9 million

Osteotech second-quarter revenue increases 2% to $24.0 million

New Irish collaborative seaweed cultivation project

Allergy shots can cause systemic side effects: Study

45-year-old Hummelstown patient takes on FDA over Johnson & Johnson’s antibiotic Levaquin

Ironwood provides investor update for second-quarter 2010

EpiCept second-quarter net loss decreases to $4.9 million

IDFA applauds U.S Senate Committee for child nutrition legislation

Sucampo Pharmaceuticals second-quarter 2010 total revenue declines to $13.8 million

mGive, disaster relief partners launch campaigns to aid flood-affected victims in Pakistan

Researchers examine differences in eating habits of African Americans

ADA commends U.S. Senate on reauthorization of child nutrition programs

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News